Luye Pharma Hong Kong Limited - Net Worth and Insider Trading

Luye Pharma Hong Kong Limited Net Worth

The estimated net worth of Luye Pharma Hong Kong Limited is at least $4.1 Billion dollars as of 2025-06-04. Luye Pharma Hong Kong Limited is the of Shandong Boan Biotechnology Co Ltd and owns about 360,596,456 shares of Shandong Boan Biotechnology Co Ltd (HKSE:06955) stock worth over $4.1 Billion. Details can be seen in Luye Pharma Hong Kong Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Luye Pharma Hong Kong Limited has not made any transactions after 2024-08-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Luye Pharma Hong Kong Limited

To

Luye Pharma Hong Kong Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Luye Pharma Hong Kong Limited owns 1 companies in total, including Shandong Boan Biotechnology Co Ltd (HKSE:06955) .

Click here to see the complete history of Luye Pharma Hong Kong Limited’s form 4 insider trades.

Insider Ownership Summary of Luye Pharma Hong Kong Limited

Ticker Company Transaction Date Type of Owner
HKSE:06955 Shandong Boan Biotechnology Co Ltd 2024-08-09

Luye Pharma Hong Kong Limited Latest Holdings Summary

Luye Pharma Hong Kong Limited currently owns a total of 1 stock. Luye Pharma Hong Kong Limited owns 360,596,456 shares of Shandong Boan Biotechnology Co Ltd (HKSE:06955) as of August 7, 2024, with a value of $4.1 Billion.

Latest Holdings of Luye Pharma Hong Kong Limited

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:06955 Shandong Boan Biotechnology Co Ltd 2024-08-07 360,596,456 11.42 4,118,011,528

Holding Weightings of Luye Pharma Hong Kong Limited


Luye Pharma Hong Kong Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, Luye Pharma Hong Kong Limited has made a total of 6 transactions in Shandong Boan Biotechnology Co Ltd (HKSE:06955) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Shandong Boan Biotechnology Co Ltd is the sale of 0 shares on August 7, 2024, which brought Luye Pharma Hong Kong Limited around $0.

Insider Trading History of Luye Pharma Hong Kong Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Luye Pharma Hong Kong Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Luye Pharma Hong Kong Limited Ownership Network

Ownership Network List of Luye Pharma Hong Kong Limited

No Data

Ownership Network Relation of Luye Pharma Hong Kong Limited

Insider Network Chart


Luye Pharma Hong Kong Limited Owned Company Details

What does Shandong Boan Biotechnology Co Ltd do?

Who are the key executives at Shandong Boan Biotechnology Co Ltd?

Luye Pharma Hong Kong Limited is the of Shandong Boan Biotechnology Co Ltd. Other key executives at Shandong Boan Biotechnology Co Ltd include 2201 Interest of corporation controlled by you Central Huijin Investment Ltd. , 2201 Interest of corporation controlled by you China Cinda Asset Management Co., Ltd. , and 2201 Interest of corporation controlled by you Li Li .

Shandong Boan Biotechnology Co Ltd (HKSE:06955) Insider Trades Summary

Over the past 18 months, Luye Pharma Hong Kong Limited made no insider transaction in Shandong Boan Biotechnology Co Ltd (HKSE:06955). Other recent insider transactions involving Shandong Boan Biotechnology Co Ltd (HKSE:06955) include a net sale of 0 shares made by LuYe Pharmaceutical Investment Co., Ltd. , a net sale of 0 shares made by Ginkgo (PTC) Limited , and a net sale of 0 shares made by Shorea LBG .

In summary, during the past 3 months, insiders sold 0 shares of Shandong Boan Biotechnology Co Ltd (HKSE:06955) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shandong Boan Biotechnology Co Ltd (HKSE:06955) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Shandong Boan Biotechnology Co Ltd (HKSE:06955)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Shandong Boan Biotechnology Co Ltd Insider Transactions

No Available Data

Luye Pharma Hong Kong Limited Mailing Address

Above is the net worth, insider trading, and ownership report for Luye Pharma Hong Kong Limited. Currently GuruFocus does not have mailing address information for Luye Pharma Hong Kong Limited.